Related Experiment Video
Updated: Feb 23, 2026

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
Filamin A (FLNA) mutation-A newcomer to the childhood interstitial lung disease (ChILD) classification
Susan C Shelmerdine1, Thomas Semple2, Colin Wallis3
1Department of Clinical Radiology, Great Ormond Street Hospital, London, UK.
Insights
Filamin A (FLNA) mutation related lung disease is a rare infant interstitial lung disease. Early identification and supportive treatment are crucial for patient management and prognostic counseling.
Area of Science:
- Pediatric Pulmonology
- Rare Genetic Disorders
- Interstitial Lung Disease
Background:
- Interstitial lung disease (ILD) in infants is a rare, heterogeneous group of disorders distinct from adult forms.
- Filamin A (FLNA) mutation-related lung disease is an emerging entity within pediatric ILD.
- Understanding FLNA-related lung disease is critical for diagnosis and management.
Observation:
- A case series of four infants with genetically confirmed FLNA mutations and ILD was reviewed.
- Radiological findings included upper lobe overinflation, septal thickening, and patchy atelectasis.
- Clinical outcomes varied significantly, including infant mortality and need for respiratory support.
Findings:
- FLNA mutations are associated with a distinct pattern of ILD in infants.
- The disease course and clinical outcomes are highly variable.
- Imaging findings provide key diagnostic clues.
Implications:
- Early identification of FLNA mutation-related lung disease is essential for appropriate patient management.
- Prognostic counseling requires understanding the variable clinical course.
- Further research into FLNA's role in lung development may reveal therapeutic targets.
Aim:
Interstitial lung disease (ILD) in infants represents a rare and heterogenous group of disorders, distinct from those occurring in adults. In recent years a new entity within this category is being recognized, namely filamin A (FLNA) mutation related lung disease. Our aims are to describe the clinical and radiological course of patients with this disease entity to aid clinicians in the prognostic counseling and management of similar patients they may encounter.
Method:
A retrospective case note review was conducted of all patients treated at our institution (a specialist tertiary referral childrens' center) for genetically confirmed FLNA mutation related lung disease. The clinical presentation, evolution, management and radiological features were recorded and a medical literature review of Medline indexed articles was conducted.
Results:
We present a case series of four patients with interstitial lung disease and genetically confirmed abnormalities within the FLNA gene. Their imaging findings all reveal a pattern of predominantly upper lobe overinflation, coarse pulmonary lobular septal thickening and diffuse patchy atelectasis. The clinical outcomes of our patients have been variable ranging from infant death, lobar resection and need for supplemental oxygen and bronchodilators.
Conclusion:
The progressive nature of the pulmonary aspect of this disorder and need for early aggressive supportive treatment make identification crucial to patient management and prognostic counseling.
Related Concept Videos
Types of Intermediate Filaments
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Cytoskeletal Linker Proteins - Plakins

